Clinical Trial Update: MSC and Kidney Transplant Tolerance (Phase A) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating mesenchymal stem cells (MSC) to promote kidney transplant tolerance in patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: Monia Lorini | Conditions: Chronic Renal Failure | Phase 1 | Status: UNKNOWN